Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

NCT04533243 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

209

Enrollment

OTHER_GOV

Sponsor class

Conditions

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive

Interventions

DRUG: 2.5ug/h transdermal fentanyl
DRUG: Oral immediate-released morphine

Sponsor

Fujian Cancer Hospital